CCR2 and breast angiosarcoma: It is reported that the infiltration of inflammatory macrophages increased in BA patients via (MCP)-1/(C-C motif) ligand 2 (CCL2) and its receptor C-C chemokine receptor 2 (CCR2) and promoted cholangiocyte injury and disease progression [5].